Compound Summary
药名: | brefeldin a |
别名: | (7S,15S,1R)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-o ne; AC1O5L8S; AKOS024282481; SR-01000597412-1; MolPort-004-955-162; NCGC00025061-02; UPCMLD-DP095:002; NCGC00025061-03; IDI1_033950; (2E,7S,10E,12R,13R,15S)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one; SR-01000597412; HMS1361J22; 1,6,7,8,9,11a?,12,13,14,14?a-Decahydro-1?,13?-dihydroxy-6?-methyl-4H-cyclopent(f)oxacyclotridecin-4-one; ST056354; UPCMLD-DP095; 4H-Cyclopent(f)oxacyclotridecin-4-one,1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-; LS-58416; CCG-208020; NSC-89671; NSC 56310; 1,6,7,8,9,11a,12,13,14,14a-Decahydro-1,13-dihydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one; (1R,6S,13S,14AR)-1,13-DIHYDROXY-6-METHYL-1H,6H,7H,8H,9H,11AH,12H,13H,14H,14AH-CYCLOPENTA[F]OXACYCLOTRIDECAN-4-ONE; HMS1989J22; 4H-Cyclopent(f)oxacyclotridecin-4-one, 1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-; NCGC00017254-03; CHEMBL1572153; HMS3402J22; HMS1791J22; UPCMLD-DP095:001; NCGC00017254-04; brefeldin A; Cyanaein; G405; 20350-15-6; SCHEMBL12648486; Cyanein; BSPBio_001480; Decumbin; (+)-Brefeldin A, Eupenicillium brefeldianum; C16H24O4 |
分子式: | C16H24O4 |
Smiles: | CC1CCCC=CC2CC(CC2C(C=CC(=O)O1)O)O |
成分: | HBIN018821 |
SymMap_id: | SMIT14500 |
TCMID_id: | 2600 |
PubChem_id: | 6436187 |
DrugBank_id: | DB07348 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE000232 | 川射干 | |||||
TCMBANKHE004258 | Radix Angelicae sinensis | 当归根 | To enrich blood, activate blood circulation, regulate menstruation, relieve pain, and relax bowels./Women’s diseases, blood deficiency syndrome, menstrual disorder, amenorrhea and dysmenorrhea, dysmenorrhea due to anemia, thrombophlebitis, neuralgia, arthritis, chronic nephritis, constrictive aortitis, blood vaculty, pernicious anemia, anemia due to folic acid deficiency, dysentery, hepatitis, Raynaud’s disease, lumbago, various pains due to blood stasis and rheumatic impediment, sores, welling abscess, constipation, ulcer in gastrointestinal tract, skin diseases, eczema, dermatitis, neurodermatitis, psoriasis. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000008 | Brain Neoplasms | group | Neoplasms; Nervous System Diseases | 29155422 |
TCMBANKDI000009 | Glioma | disease | Neoplasms | 29155422 |
TCMBANKDI000047 | Neoplasm Metastasis | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 27065333 |
TCMBANKDI000085 | Inflammation | phenotype | Pathological Conditions, Signs and Symptoms | 24198377 |
TCMBANKDI000088 | Lung Neoplasms | group | Neoplasms; Respiratory Tract Diseases | 25011082 |
TCMBANKDI002742 | Polycystic Kidney Diseases | group | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 24627348 |
TCMBANKDI007361 | Multiple Myeloma | disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 28211573 |
TCMBANKDI015740 | Colorectal Neoplasms | group | Digestive System Diseases; Neoplasms | 30668917 |
TCMBANKDI023555 | Hypoxia | phenotype | Pathological Conditions, Signs and Symptoms | 29155422 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000047 | AKT1 | AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA | AKT serine/threonine kinase 1 |
TCMBANKGE000105 | KIF5B | HEL-S-61; KINH; KNS; KNS1; UKHC | kinesin family member 5B |
TCMBANKGE000106 | SCN10A | FEPS2; Nav1.8; PN3; SNS; hPN3 | sodium voltage-gated channel alpha subunit 10 |
TCMBANKGE000107 | ARFGEF3 | A7322; BIG3; C6orf92; KIAA1244; PPP1R33; dJ171N11.1 | ARFGEF family member 3 |
TCMBANKGE000108 | COMP | EDM1; EPD1; MED; PSACH; THBS5; TSP5 | cartilage oligomeric matrix protein |
TCMBANKGE000250 | CCL5 | D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP | C-C motif chemokine ligand 5 |
TCMBANKGE000274 | CCL2 | GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF | C-C motif chemokine ligand 2 |
TCMBANKGE000553 | GDF10 | BIP; BMP-3b; BMP3B | growth differentiation factor 10 |
TCMBANKGE000696 | PKD1 | PBP; PC1; Pc-1; TRPP1 | polycystin 1, transient receptor potential channel interacting |
TCMBANKGE001027 | STK11 | LKB1; PJS; hLKB1 | serine/threonine kinase 11 |
TCMBANKGE001050 | PKD2 | APKD2; PC2; PKD4; Pc-2; TRPP2 | polycystin 2, transient receptor potential cation channel |
TCMBANKGE001068 | CXCL1 | FSP; GRO1; GROa; MGSA; MGSA-a; NAP-3; SCYB1 | C-X-C motif chemokine ligand 1 |
TCMBANKGE001114 | IL6 | BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6 | interleukin 6 |
TCMBANKGE001148 | VEGFA | MVCD1; VEGF; VPF | vascular endothelial growth factor A |